| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T115 |
0-89 |
Sentence |
denotes |
Table 2 Comparison of CT findings and scores between two groups in patients with COVID-19 |
| T116 |
90-167 |
Sentence |
denotes |
Variables Early-stage group (n = 34) Progressive-stage group (n = 28) p value |
| T117 |
168-179 |
Sentence |
denotes |
CT findings |
| T118 |
180-234 |
Sentence |
denotes |
Ground-glass opacity 22 (64.7%) 16 (57.1%) 0.543 (χ) |
| T119 |
235-276 |
Sentence |
denotes |
Consolidation 1 (2.9%) 0 (0%) 1.000 (χ) |
| T120 |
277-350 |
Sentence |
denotes |
Ground-glass opacity with consolidation 11 (32.4%) 11 (39.3%) 0.570 (χ) |
| T121 |
351-376 |
Sentence |
denotes |
Reticular pattern 0 0 – |
| T122 |
377-406 |
Sentence |
denotes |
Nodule 1 (2.9%) 0 1.000 (χ) |
| T123 |
407-457 |
Sentence |
denotes |
Rounded opacities 10 (29.4%) 6 (21.4%) 0.475 (χ) |
| T124 |
458-476 |
Sentence |
denotes |
Cavitation 0 0 – |
| T125 |
477-529 |
Sentence |
denotes |
Crazy-paving pattern 8 (23.5%) 8 (28.6%) 0.652 (χ) |
| T126 |
530-577 |
Sentence |
denotes |
Air bronchogram 8 (23.5%) 6 (21.4%) 0.844 (χ) |
| T127 |
578-611 |
Sentence |
denotes |
Halo sign 7 (20.6%) 0 0.013 (χ) |
| T128 |
612-645 |
Sentence |
denotes |
Bronchial wall thickening 0 0 – |
| T129 |
646-704 |
Sentence |
denotes |
Subpleural curvilinear line 4 (11.8%) 2 (7.1%) 0.681 (χ) |
| T130 |
705-752 |
Sentence |
denotes |
Thoracic lymphadenopathy 0 1 (3.6%) 0.452 (χ) |
| T131 |
753-813 |
Sentence |
denotes |
Pleural effusion or thickening 1 (2.9%) 1 (3.6%) 1.000 (χ) |
| T132 |
814-855 |
Sentence |
denotes |
Pulmonary fibrosis 0 1 (3.6%) 0.452 (χ) |
| T133 |
856-915 |
Sentence |
denotes |
Max diameter of lesion (cm) 4.27 ± 2.66 5.83 ± 3.76 0.059 |
| T134 |
916-946 |
Sentence |
denotes |
< 1 cm 0 1 (3.6) 0.201 (χ) |
| T135 |
947-980 |
Sentence |
denotes |
1–2.9 cm 13 (38.2%) 5 (17.9%) |
| T136 |
981-1015 |
Sentence |
denotes |
3–4.9 cm 12 (35.3%) 10 (35.7%) |
| T137 |
1016-1047 |
Sentence |
denotes |
> 5 cm 9 (26.5%) 12 (42.9%) |
| T138 |
1048-1060 |
Sentence |
denotes |
Distribution |
| T139 |
1061-1098 |
Sentence |
denotes |
Central 1 (2.9%) 1 (3.6%) 0.961 (χ) |
| T140 |
1099-1132 |
Sentence |
denotes |
Peripheral 12 (35.3%) 9 (32.1%) |
| T141 |
1133-1184 |
Sentence |
denotes |
Both central and peripheral 21 (61.8%) 18 (64.3%) |
| T142 |
1185-1223 |
Sentence |
denotes |
CT score 4.79 ± 2.76 7.79 ± 4.62 0.004 |
| T143 |
1224-1261 |
Sentence |
denotes |
0–5 27 (79.4%) 10 (35.7%) 0.004 (χ) |
| T144 |
1262-1289 |
Sentence |
denotes |
6–10 6 (17.6%) 12 (42.9%) |
| T145 |
1290-1309 |
Sentence |
denotes |
11–15 0 3 (10.7%) |
| T146 |
1310-1335 |
Sentence |
denotes |
> 15 1 (2.9%) 3 (10.7%) |
| T147 |
1336-1370 |
Sentence |
denotes |
COVID-19, coronavirus disease 2019 |
